ÂÜÀòÂÒÂ×

Praveena Kanapathypillai is a Scientist at Adaptimmune since May 2022, specializing in Allogeneic Process Development. Previously, Praveena served as an Associate Scientist at AstraZeneca from August 2019 to August 2020, focusing on cell culture and banking processes to support drug discovery projects. Prior experience includes an Associate Research Scientist role at GSK from October 2018 to August 2019, contributing to T cell immunotherapy research in various disciplines such as cell and viral vector formulation. Praveena holds a Master of Science degree in Manufacture and Commercialisation of Stem Cell and Gene Therapies from UCL (2020-2021) and a Bachelor of Science (BSc) Honours in Biomedical Science from Coventry University (2015-2018).